A randomised phase II multicentre study of ipilimumab with temozolomide vs temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: Ipi-Glio
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Conference item |
Language: | English |
Published: |
American Society of Clinical Oncology
2023
|